 | • レポートコード：D0GIR-02331 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、モサプリドの世界市場を広く調査・分析し、今後の市場展望をまとめております。モサプリドの種類別市場規模（タブレット、カプセル、その他）、用途別市場規模（胃炎、消化不良、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Sumitomo Dainippon Pharma、DAIICHI SANKYO、Nihon Generic、Konghong Pharmaceutical、HAOSON PHARMA、Dainippon Pharmaceutical Co., Ltd.、Lunan Pharmaceutical Group、NIPPON CHEMIPHAR CO., LTD.、SAWAI PHARMACEUTICAL CO., LTD. ・地域別グローバル市場分析 2015年-2020年 ・モサプリドの北米市場（アメリカ、カナダ、メキシコ） ・モサプリドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・モサプリドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・モサプリドの南米市場（ブラジル、アルゼンチン） ・モサプリドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：タブレット、カプセル、その他 ・用途別分析：胃炎、消化不良、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Mosapride market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Mosapride sales will be xx in 2020 from Mosapride million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Mosapride market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Mosapride industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Mosapride and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Mosapride market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Mosapride market has been segmented into:
Tablet
Capsule
Others
By Application, Mosapride has been segmented into:
Gastritis
Dyspepsia
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Mosapride market presented in the report. This section sheds light on the sales growth of different regional and country-level Mosapride markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Mosapride market.
The report offers in-depth assessment of the growth and other aspects of the Mosapride market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Mosapride Market Share Analysis
Mosapride competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Mosapride sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Mosapride sales, revenue and market share for each player covered in this report.
The major players covered in Mosapride are:
Sumitomo Dainippon Pharma
DAIICHI SANKYO
Nihon Generic
Konghong Pharmaceutical
HAOSON PHARMA
Dainippon Pharmaceutical Co., Ltd.
Lunan Pharmaceutical Group
NIPPON CHEMIPHAR CO., LTD.
SAWAI PHARMACEUTICAL CO., LTD.
Among other players domestic and global, Mosapride market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Mosapride Market Overview
1.1 Product Overview and Scope of Mosapride
1.2 Classification of Mosapride by Type
1.2.1 Global Mosapride Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Mosapride Revenue Market Share by Type in 2019
1.2.3 Tablet
1.2.4 Capsule
1.2.5 Others
1.3 Global Mosapride Market by Application
1.3.1 Overview: Global Mosapride Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Gastritis
1.3.3 Dyspepsia
1.3.4 Others
1.4 Global Mosapride Market by Regions
1.4.1 Global Mosapride Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Mosapride (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Mosapride Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Mosapride Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mosapride Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Mosapride Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mosapride Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Mosapride Industry Impact
1.5.1 COVID-19 Potential Implications for the Mosapride
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Mosapride
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Sumitomo Dainippon Pharma
2.1.1 Sumitomo Dainippon Pharma Details
2.1.2 Sumitomo Dainippon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sumitomo Dainippon Pharma SWOT Analysis
2.1.4 Sumitomo Dainippon Pharma Product and Services
2.1.5 Sumitomo Dainippon Pharma Mosapride Revenue, Gross Margin and Market Share (2018-2019)
2.2 DAIICHI SANKYO
2.2.1 DAIICHI SANKYO Details
2.2.2 DAIICHI SANKYO Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DAIICHI SANKYO SWOT Analysis
2.2.4 DAIICHI SANKYO Product and Services
2.2.5 DAIICHI SANKYO Mosapride Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nihon Generic
2.3.1 Nihon Generic Details
2.3.2 Nihon Generic Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Nihon Generic SWOT Analysis
2.3.4 Nihon Generic Product and Services
2.3.5 Nihon Generic Mosapride Revenue, Gross Margin and Market Share (2018-2019)
2.4 Konghong Pharmaceutical
2.4.1 Konghong Pharmaceutical Details
2.4.2 Konghong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Konghong Pharmaceutical SWOT Analysis
2.4.4 Konghong Pharmaceutical Product and Services
2.4.5 Konghong Pharmaceutical Mosapride Revenue, Gross Margin and Market Share (2018-2019)
2.5 HAOSON PHARMA
2.5.1 HAOSON PHARMA Details
2.5.2 HAOSON PHARMA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 HAOSON PHARMA SWOT Analysis
2.5.4 HAOSON PHARMA Product and Services
2.5.5 HAOSON PHARMA Mosapride Revenue, Gross Margin and Market Share (2018-2019)
2.6 Dainippon Pharmaceutical Co., Ltd.
2.6.1 Dainippon Pharmaceutical Co., Ltd. Details
2.6.2 Dainippon Pharmaceutical Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Dainippon Pharmaceutical Co., Ltd. SWOT Analysis
2.6.4 Dainippon Pharmaceutical Co., Ltd. Product and Services
2.6.5 Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lunan Pharmaceutical Group
2.7.1 Lunan Pharmaceutical Group Details
2.7.2 Lunan Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lunan Pharmaceutical Group SWOT Analysis
2.7.4 Lunan Pharmaceutical Group Product and Services
2.7.5 Lunan Pharmaceutical Group Mosapride Revenue, Gross Margin and Market Share (2018-2019)
2.8 NIPPON CHEMIPHAR CO., LTD.
2.8.1 NIPPON CHEMIPHAR CO., LTD. Details
2.8.2 NIPPON CHEMIPHAR CO., LTD. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 NIPPON CHEMIPHAR CO., LTD. SWOT Analysis
2.8.4 NIPPON CHEMIPHAR CO., LTD. Product and Services
2.8.5 NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue, Gross Margin and Market Share (2018-2019)
2.9 SAWAI PHARMACEUTICAL CO., LTD.
2.9.1 SAWAI PHARMACEUTICAL CO., LTD. Details
2.9.2 SAWAI PHARMACEUTICAL CO., LTD. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 SAWAI PHARMACEUTICAL CO., LTD. SWOT Analysis
2.9.4 SAWAI PHARMACEUTICAL CO., LTD. Product and Services
2.9.5 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Mosapride Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Mosapride Players Market Share
3.2.2 Top 10 Mosapride Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Mosapride Revenue and Market Share by Regions
4.2 North America Mosapride Revenue and Growth Rate (2015-2020)
4.3 Europe Mosapride Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Mosapride Revenue and Growth Rate (2015-2020)
4.5 South America Mosapride Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Mosapride Revenue and Growth Rate (2015-2020)
5 North America Mosapride Revenue by Countries
5.1 North America Mosapride Revenue by Countries (2015-2020)
5.2 USA Mosapride Revenue and Growth Rate (2015-2020)
5.3 Canada Mosapride Revenue and Growth Rate (2015-2020)
5.4 Mexico Mosapride Revenue and Growth Rate (2015-2020)
6 Europe Mosapride Revenue by Countries
6.1 Europe Mosapride Revenue by Countries (2015-2020)
6.2 Germany Mosapride Revenue and Growth Rate (2015-2020)
6.3 UK Mosapride Revenue and Growth Rate (2015-2020)
6.4 France Mosapride Revenue and Growth Rate (2015-2020)
6.5 Russia Mosapride Revenue and Growth Rate (2015-2020)
6.6 Italy Mosapride Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Mosapride Revenue by Countries
7.1 Asia-Pacific Mosapride Revenue by Countries (2015-2020)
7.2 China Mosapride Revenue and Growth Rate (2015-2020)
7.3 Japan Mosapride Revenue and Growth Rate (2015-2020)
7.4 Korea Mosapride Revenue and Growth Rate (2015-2020)
7.5 India Mosapride Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Mosapride Revenue and Growth Rate (2015-2020)
8 South America Mosapride Revenue by Countries
8.1 South America Mosapride Revenue by Countries (2015-2020)
8.2 Brazil Mosapride Revenue and Growth Rate (2015-2020)
8.3 Argentina Mosapride Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Mosapride by Countries
9.1 Middle East & Africa Mosapride Revenue by Countries (2015-2020)
9.2 Saudi Arabia Mosapride Revenue and Growth Rate (2015-2020)
9.3 UAE Mosapride Revenue and Growth Rate (2015-2020)
9.4 Egypt Mosapride Revenue and Growth Rate (2015-2020)
9.5 South Africa Mosapride Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Mosapride Revenue and Market Share by Type (2015-2020)
10.2 Global Mosapride Market Forecast by Type (2019-2024)
10.3 Tablet Revenue Growth Rate (2015-2025)
10.4 Capsule Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Mosapride Market Segment by Application
11.1 Global Mosapride Revenue Market Share by Application (2015-2020)
11.2 Mosapride Market Forecast by Application (2019-2024)
11.3 Gastritis Revenue Growth (2015-2020)
11.4 Dyspepsia Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Mosapride Market Size Forecast (2021-2025)
12.1 Global Mosapride Market Size Forecast (2021-2025)
12.2 Global Mosapride Market Forecast by Regions (2021-2025)
12.3 North America Mosapride Revenue Market Forecast (2021-2025)
12.4 Europe Mosapride Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Mosapride Revenue Market Forecast (2021-2025)
12.6 South America Mosapride Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Mosapride Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Mosapride Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Mosapride by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Mosapride Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Mosapride Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Mosapride Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Sumitomo Dainippon Pharma Corporate Information, Location and Competitors
Table 7. Sumitomo Dainippon Pharma Mosapride Major Business
Table 8. Sumitomo Dainippon Pharma Mosapride Total Revenue (USD Million) (2017-2018)
Table 9. Sumitomo Dainippon Pharma SWOT Analysis
Table 10. Sumitomo Dainippon Pharma Mosapride Product and Solutions
Table 11. Sumitomo Dainippon Pharma Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. DAIICHI SANKYO Corporate Information, Location and Competitors
Table 13. DAIICHI SANKYO Mosapride Major Business
Table 14. DAIICHI SANKYO Mosapride Total Revenue (USD Million) (2018-2019)
Table 15. DAIICHI SANKYO SWOT Analysis
Table 16. DAIICHI SANKYO Mosapride Product and Solutions
Table 17. DAIICHI SANKYO Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Nihon Generic Corporate Information, Location and Competitors
Table 19. Nihon Generic Mosapride Major Business
Table 20. Nihon Generic Mosapride Total Revenue (USD Million) (2017-2018)
Table 21. Nihon Generic SWOT Analysis
Table 22. Nihon Generic Mosapride Product and Solutions
Table 23. Nihon Generic Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Konghong Pharmaceutical Corporate Information, Location and Competitors
Table 25. Konghong Pharmaceutical Mosapride Major Business
Table 26. Konghong Pharmaceutical Mosapride Total Revenue (USD Million) (2017-2018)
Table 27. Konghong Pharmaceutical SWOT Analysis
Table 28. Konghong Pharmaceutical Mosapride Product and Solutions
Table 29. Konghong Pharmaceutical Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. HAOSON PHARMA Corporate Information, Location and Competitors
Table 31. HAOSON PHARMA Mosapride Major Business
Table 32. HAOSON PHARMA Mosapride Total Revenue (USD Million) (2017-2018)
Table 33. HAOSON PHARMA SWOT Analysis
Table 34. HAOSON PHARMA Mosapride Product and Solutions
Table 35. HAOSON PHARMA Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Dainippon Pharmaceutical Co., Ltd. Corporate Information, Location and Competitors
Table 37. Dainippon Pharmaceutical Co., Ltd. Mosapride Major Business
Table 38. Dainippon Pharmaceutical Co., Ltd. Mosapride Total Revenue (USD Million) (2017-2018)
Table 39. Dainippon Pharmaceutical Co., Ltd. SWOT Analysis
Table 40. Dainippon Pharmaceutical Co., Ltd. Mosapride Product and Solutions
Table 41. Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Lunan Pharmaceutical Group Corporate Information, Location and Competitors
Table 43. Lunan Pharmaceutical Group Mosapride Major Business
Table 44. Lunan Pharmaceutical Group Mosapride Total Revenue (USD Million) (2017-2018)
Table 45. Lunan Pharmaceutical Group SWOT Analysis
Table 46. Lunan Pharmaceutical Group Mosapride Product and Solutions
Table 47. Lunan Pharmaceutical Group Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. NIPPON CHEMIPHAR CO., LTD. Corporate Information, Location and Competitors
Table 49. NIPPON CHEMIPHAR CO., LTD. Mosapride Major Business
Table 50. NIPPON CHEMIPHAR CO., LTD. Mosapride Total Revenue (USD Million) (2017-2018)
Table 51. NIPPON CHEMIPHAR CO., LTD. SWOT Analysis
Table 52. NIPPON CHEMIPHAR CO., LTD. Mosapride Product and Solutions
Table 53. NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. SAWAI PHARMACEUTICAL CO., LTD. Corporate Information, Location and Competitors
Table 55. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Major Business
Table 56. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Total Revenue (USD Million) (2017-2018)
Table 57. SAWAI PHARMACEUTICAL CO., LTD. SWOT Analysis
Table 58. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product and Solutions
Table 59. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Mosapride Revenue (Million USD) by Players (2015-2020)
Table 61. Global Mosapride Revenue Share by Players (2015-2020)
Table 62. Global Mosapride Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Mosapride Revenue Market Share by Regions (2015-2020)
Table 64. North America Mosapride Revenue by Countries (2015-2020)
Table 65. North America Mosapride Revenue Market Share by Countries (2015-2020)
Table 66. Europe Mosapride Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Mosapride Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Mosapride Revenue by Countries (2015-2020)
Table 69. South America Mosapride Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Mosapride Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Mosapride Revenue Market Share by Countries (2015-2020)
Table 72. Global Mosapride Revenue (Million USD) by Type (2015-2020)
Table 73. Global Mosapride Revenue Share by Type (2015-2020)
Table 74. Global Mosapride Revenue Forecast by Type (2021-2025)
Table 75. Global Mosapride Revenue by Application (2015-2020)
Table 76. Global Mosapride Revenue Share by Application (2015-2020)
Table 77. Global Mosapride Revenue Forecast by Application (2021-2025)
Table 78. Global Mosapride Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Mosapride Picture
Figure 2. Global Mosapride Revenue Market Share by Type in 2019
Figure 3. Tablet Picture
Figure 4. Capsule Picture
Figure 5. Others Picture
Figure 6. Mosapride Revenue Market Share by Application in 2019
Figure 7. Gastritis Picture
Figure 8. Dyspepsia Picture
Figure 9. Others Picture
Figure 10. Global Mosapride Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Mosapride Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Mosapride Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Mosapride Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Mosapride Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Mosapride Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Mosapride Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Mosapride Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Mosapride Revenue Market Share in 2019
Figure 19. Global Top 10 Players Mosapride Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Mosapride Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Mosapride Revenue Market Share by Regions (2015-2020)
Figure 23. Global Mosapride Revenue Market Share by Regions in 2018
Figure 24. North America Mosapride Revenue and Growth Rate (2015-2020)
Figure 25. Europe Mosapride Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Mosapride Revenue and Growth Rate (2015-2020)
Figure 27. South America Mosapride Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Mosapride Revenue and Growth Rate (2015-2020)
Figure 29. North America Mosapride Revenue Market Share by Countries (2015-2020)
Figure 30. North America Mosapride Revenue Market Share by Countries in 2019
Figure 31. USA Mosapride Revenue and Growth Rate (2015-2020)
Figure 32. Canada Mosapride Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Mosapride Revenue and Growth Rate (2015-2020)
Figure 34. Europe Mosapride Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Mosapride Revenue Market Share by Countries in 2019
Figure 36. Germany Mosapride Revenue and Growth Rate (2015-2020)
Figure 37. UK Mosapride Revenue and Growth Rate (2015-2020)
Figure 38. France Mosapride Revenue and Growth Rate (2015-2020)
Figure 39. Russia Mosapride Revenue and Growth Rate (2015-2020)
Figure 40. Italy Mosapride Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Mosapride Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Mosapride Revenue Market Share by Countries in 2019
Figure 43. China Mosapride Revenue and Growth Rate (2015-2020)
Figure 44. Japan Mosapride Revenue and Growth Rate (2015-2020)
Figure 45. Korea Mosapride Revenue and Growth Rate (2015-2020)
Figure 46. India Mosapride Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Mosapride Revenue and Growth Rate (2015-2020)
Figure 48. South America Mosapride Revenue Market Share by Countries (2015-2020)
Figure 49. South America Mosapride Revenue Market Share by Countries in 2019
Figure 50. Brazil Mosapride Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Mosapride Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Mosapride Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Mosapride Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Mosapride Revenue and Growth Rate (2015-2020)
Figure 55. UAE Mosapride Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Mosapride Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Mosapride Revenue and Growth Rate (2015-2020)
Figure 58. Global Mosapride Revenue Share by Type (2015-2020)
Figure 59. Global Mosapride Revenue Share by Type in 2019
Figure 60. Global Mosapride Market Share Forecast by Type (2021-2025)
Figure 61. Global Tablet Revenue Growth Rate (2015-2020)
Figure 62. Global Capsule Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Mosapride Revenue Share by Application (2015-2020)
Figure 65. Global Mosapride Revenue Share by Application in 2019
Figure 66. Global Mosapride Market Share Forecast by Application (2021-2025)
Figure 67. Global Gastritis Revenue Growth Rate (2015-2020)
Figure 68. Global Dyspepsia Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Mosapride Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Mosapride Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Mosapride Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Mosapride Revenue Market Forecast (2021-2025)
Figure 74. Europe Mosapride Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Mosapride Revenue Market Forecast (2021-2025)
Figure 76. South America Mosapride Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Mosapride Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
胃炎治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Gastritis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gastritis Treatment marke…- 胃炎治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Gastritis Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gastritis Therapeutics…
- エベロリムス錠の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Everolimus Tablet market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Everolimus Tablet market re…
- 双黄連カプセルの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Shuanghuanglian Capsule market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- カプセルホテルの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Capsule Hotel market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.7% in the forecast period of 2020 to 2025 and will expected to reach USD 231.2 million by 2025, from USD 184.9 million in 2019. The Capsule Hotel market rep…